UNVEILING THE BURDEN OF CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS ACROSS CLINICAL SETTINGS: A REVIEW OF INCIDENCE, RISK FACTORS, AND OUTCOMES
Magna Scientia Advanced Research and Reviews · 01.11.2026 · 18 (2) · 037
DOI: 10.30574/msarr.2026.18.2.0230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magna Scientia Advanced Research and Reviews, online erschienen am 01.11.2026. Verfasst von Bunga Ayasi Krisania und 2 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Central line-associated bloodstream infection (CLABSI) remains a significant healthcare-associated complication linked to morbidity, prolonged hospitalization, increased healthcare costs, and mortality. Its burden varies across clinical settings and is influenced by patient characteristics, catheter exposure, healthcare practices, and surveillance methods. This review aims to synthesize evidence published between 2016 and 2026 regarding CLABSI incidence, risk factors, microbiological characteristics, clinical outcomes, and prevention across diverse healthcare settings. The review examines evidence from intensive care units, general medical and surgical wards, oncology and hematology, neonatal and pediatric units, and hemodialysis settings, considering differences in surveillance definitions and study populations. Reported CLABSI rates varied across settings. Multinational intensive care unit surveillance reported a pooled rate of 4.82 infections per 1,000 central-line days, whereas multicenter surveillance in India reported 8.83 infections per 1,000 central-line days, with the highest rate observed in neonatal intensive care units. Reported risk factors included prolonged catheterization, multilumen catheters, repeated catheterization episodes, severe illness, immunosuppression, older age, diabetes mellitus, parenteral nutrition, and inconsistent adherence to infection-prevention practices. CLABSI was associated with sepsis, prolonged hospitalization, recurrent infection, catheter removal or replacement, increased healthcare costs, and mortality. However, these outcomes require cautious interpretation because of differences in case definitions, baseline illness severity, and surveillance practices. In conclusion, CLABSI remains an important concern across clinical settings. Prevention requires appropriate catheter selection, aseptic insertion and maintenance, healthcare worker training, consistent surveillance, and timely removal of unnecessary catheters. Standardized definitions, exposure-adjusted reporting, and robust multicenter studies are needed to improve comparisons and clarify clinical outcomes.
Zitieren
APA
Krisania, B. A., Wardhani, P., & Tjempakasari, A. (2026). UNVEILING THE BURDEN OF CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS ACROSS CLINICAL SETTINGS: A REVIEW OF INCIDENCE, RISK FACTORS, AND OUTCOMES. Magna Scientia Advanced Research and Reviews, 18(2), 037. https://doi.org/10.30574/msarr.2026.18.2.0230
Vancouver
Krisania BA, Wardhani P, Tjempakasari A. UNVEILING THE BURDEN OF CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS ACROSS CLINICAL SETTINGS: A REVIEW OF INCIDENCE, RISK FACTORS, AND OUTCOMES. Magna Scientia Advanced Research and Reviews. 2026;18(2):037. doi:10.30574/msarr.2026.18.2.0230
BibTeX
@article{Krisania2026,
author = {Krisania, Bunga Ayasi and Wardhani, Puspa and Tjempakasari, Artaria},
title = {UNVEILING THE BURDEN OF CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS ACROSS CLINICAL SETTINGS: A REVIEW OF INCIDENCE, RISK FACTORS, AND OUTCOMES},
journal = {Magna Scientia Advanced Research and Reviews},
year = {2026},
volume = {18},
number = {2},
pages = {037},
doi = {10.30574/msarr.2026.18.2.0230}
}
EUVIMED